Results 51 to 60 of about 24,660,605 (261)

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman, Deborah Meyran, Vajiranee Malalasekera, Heather Weerdenburg, Janine Campbell, Rachel Conyers, Stacie Wang, Hannah Walker, Seong Lin Khaw, Diane Hanna   +9 more
wiley   +1 more source

Working capital and R&D smoothing: evidence from the Tel Aviv stock exchange

Journal of Applied Economics, 2021
This paper proposes new tests for financing constraints on R&D investment by directly examining the role played by working capital in smoothing the R&D expenditures of firms listed on the Tel Aviv stock exchange.
Ahmad Alkhataybeh
doaj   +1 more source

Language, Culture, and Cancer: Qualitative Insights Into Communication Disparities Among Spanish‐Speaking Caregivers of Children With Cancer

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Latino children are projected to make up nearly one‐third of United States (US) children by 2060, and many of their caregivers speak Spanish. Prior survey research has documented communication difficulties for Spanish‐speaking caregivers of children with cancer, but contemporary qualitative data are limited.
Jenny Ruiz, Alejandra Curbelo‐Paz, Sonia Morales, Elizabeth Contreras, Amy Houtrow, Scott H. Maurer, Judy C. Chang   +6 more
wiley   +1 more source

Impact of board characteristics and gender diversity on research and development spending in Jordan [PDF]

Problems and Perspectives in Management
This study undertakes an investigation into the nexus between board characteristics and research and development (R&D) investments within the specific context of Jordan.
Dua’a Shubita, Majd Munir Iskandrani, Hadeel Boshmaf, Hadeel Yaseen, Mohammad Fawzi Shubita   +4 more
doaj   +1 more source

Biphasic Clinical Course of Pediatric Cytomegalovirus‐Associated Immune Thrombocytopenia: Early Poor Treatment Response but Favorable Long‐Term Outcomes

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad, Ohad Atia, Osama Tanous, Dafna Brik Simon, Michal Dvori, Miriam Cohen, Tracie A. Goldberg, Efraim Bilavsky, Joanne Yacobovich, Orna Steinberg‐Shemer   +9 more
wiley   +1 more source

EFFECTS OF FIRM-SPECIFIC FACTORS ON R&D EXPENDITURES OF AGRIBUSINESS COMPANIES [PDF]

The objective of this paper is to determine how the firm's infrastructure, the financial characteristics of a company (net income, sales), and the organizational structure (number of acquisitions, age of establishment of the firm) affect R&D investments ...
David UBILAVA, Maud ROUCAN-KANE, Pei XU
core  

Bone Mineral Density After Contemporary Treatment for Acute Lymphoblastic Leukaemia: A Matched Cross‐Sectional Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Reduced bone mineral density (BMD) has been reported in survivors of childhood and young adult acute lymphoblastic leukaemia (ALL); however, data from cohorts treated with contemporary protocols and including matched controls remain limited.
Karen Schow Jensen, Mette Tiedemann Skipper, Niels Holtum Birkebæk, Kjeld Schmiegelow, Thomas Leth Frandsen, Bente Langdahl, Rikke Beck Jensen, Asger Roer Pedersen, Christian Mølgaard, Liv Andrés‐Jensen, Birgitte Klug Albertsen   +10 more
wiley   +1 more source

International R & D expenditures and external technology sourcing. [PDF]

The paper examines the two-way relationship between external R&D activities and internal R&D expenditures on a cross-section of Flemish R&D active companies.
Veugelers, Reinhilde
core  

1.2. Vorlesung (27.04.2020): R&D expenditures compared

, 2020
Content: R&D expenditures funding and performing sectors; R&D expenditures by performing sectors and by department; International comparison of R&D intensities; Government share in R&D expenditure; Military research; University research; R&D ...
Graf, Holger
core  

THE KEY ACTORS OF KNOWLEDGE PRODUCTION FUNCTION IN TURKEY: THE ROLE OF UNIVERSITIES AS A KNOWLEDGE PRODUCER

SDÜ Vizyoner Dergisi, 2020
By taking the projects which are carried out in the universities in Turkey and are funded by the Scientific and Technological Research Council (TÜBİTAK) as an output, the paper tries to estimate the knowledge production function of Turkey.
Aykut Sezgin, Selen Işık Maden, Sevim Unutulmaz, Murat Dulupçu, Ayşegül Baykul   +4 more
doaj   +1 more source